Of note, we recently reported that mutations commonly found in patients with non-small-cell lung cancer were not detected in penile cancer patients [20], which shows that the biological mechanism underlying EGFR activation remains to be fully explored. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.